Anabolic Therapy for Osteoporosis

Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac ...  Show more

In the US, approximately 66% of reproductive-aged women have at least 1 modifiable risk factor for adverse pregnancy outcomes. Authors and ob-gyns Kylie Cooper, MD, and Daniel Breitkopf, MD, both from the Mayo Clinic, discuss ways to reduce maternal morbidity and mortality and im ...  Show more

To claim credit for this episode, visit: www.ce.mayo.edu/regmedonline

Guest: Daniel Saris, M.D., Ph.D. (@sarisnl)

Host: Darryl S. Chutka, M.D. (<a href='https://twitter.co ...

Prolozone and Nutritional Therapy for Osteoarthritis with Dr. George Papanicolaou | This episode is sponsored by AirDoctor Millions of Americans suffer from chronic joint pain, most commonly in the knee, due to osteoarthritis. Conventional medicine typically treats the symptoms o ...  Show more

Podcast with Dr. Cole and Steve Kashul, joined by Josh Hannan, PA-C, MS, CAQ, to discuss bone-cartilage transplants and alternatives to early joint replacement madeContinue readingThe post How osteochondral allografts are made possible appeared first on Sports Medicine Weekly. 

In this episode Richard Cheng MD and Michelle Kittleson MD discuss treatment for amyloidosis, including evidence-based therapies, pitfalls, and advanced heart failure management. This podcast is part of the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment grant initiativ ...  Show more